More Investing
View Older Stories View Newer Stories-
Deutsche Bank lowers PepsiCo rating as turnaround now more complicated
-
J.P. Morgan flags negative catalyst at Haleon on weak sales momentum
-
Snowflake shares slide as $3.5B debt offering sparks dilution jitters
-
Jefferies sees signs of softer iPhone 18 demand
-
Saudi Arabia resumes Yanbu oil exports after pipeline repair
-
Jefferies cuts Roblox to Underperform, says rally is too optimistic
-
Premarket movers Boeing falls on software glitch; Kodiak surges
-
October Fed meeting hinges on this key economic data, Citi says
-
Nvidia’s AI dominance funds historic $150 billion buyback
-
What will it take to fix the market’s weak breadth? Morgan Stanley weighs in
-
European gas jumps 3% as Middle-East talks hits stalemate
-
Evercore sees yield-curve inversion risk rising as AI bull market holds firm
-
Trump rejects Iran proposal; OpenAI pause weighs on tech - what’s moving markets
-
TotalEnergies rises after dividend, buyback plans and output target through 2035
-
Nvidia launches AI security tools to prevent agent breaches
-
S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
-
B. Riley Securities Names Top Pick in Financial Services Sector
-
Circle stock dips as CFO Fox-Geen steps down and co-founder leaves board
-
RegenLab targets Nasdaq listing under ticker RGNA as revenues top $29 million
-
Moody’s raises BJ’s Wholesale outlook to positive on debt reduction
-
Moody’s upgrades Cushman & Wakefield rating to Ba3 on debt reduction
-
Moody’s upgrades Brinker to Ba1 on Chili’s growth and debt reduction
-
Rithm Capital earns S&P upgrade to ’B+’ following steady revenue diversification
-
S&P downgrades Cable One to ’B+’ on weakening broadband outlook
-
Canadian dollar faces near-term pressure as rate gap and trade risks widen
-
Oura IPO said to draw four times demand as orders near close
-
Viatris sues Novo Nordisk over generic Wegovy patent dispute
-
Humana surges: Barclays bets big on Medicare star ratings rebound
-
Fed’s Hammack says public’s inflation expectations could worsen
-
Investing.com’s stocks of the week
-
SK Hynix’s Solidigm said to mull IPO that could value unit at $150B
-
Anthropic supply-chain designation upheld in AI military dispute
-
Meta jury finds company misled New Mexico residents
-
Nscale secures $3.36 billion pre-IPO round as public debut looms
-
Webull working with regulators as AI trading evolves
-
CrowdStrike probe closed by US prosecutors without charges
-
Bill Gates demands federal AI guardrails, warns of "a billion deaths"
-
Cognition AI hits $1 billion run rate amid demand for coding software - Bloomberg
-
B. Riley’s Top Biotech Picks Ahead of 3Q26 Earnings Season
-
Mizuho bullish on Tower Semiconductor, points to AI optical growth
-
BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
-
Fed’s Schmid questions if AI ecosystem is "too-big-to-fail"
-
Adarx Pharmaceuticals allocates 55% of IPO to 10 investors
-
Canadian boards have an AI problem — what is it?
-
KeyBanc gets bearish on Comcast as broadband competition intensifies
-
HSBC cuts Twilio to Reduce, says Muse rally has gone too far
-
Stifel starts Almonty with $25 price target on Western tungsten expansion
-
CoreCivic shares slip following unexpected CEO transition
-
Nektar Therapeutics stock rises on $90M jury verdict vs Lilly
-
Tesla faces production challenges with Optimus robot hands, report says
